T. Rowe Price Associates’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
15,055
+4,040
| +37% | +$373K | ﹤0.01% | 1821 |
|
|
2025
Q1 | $977K | Sell |
11,015
-55,953
| -84% | -$4.96M | ﹤0.01% | 1966 |
|
|
2024
Q4 | $5.15M | Buy |
66,968
+3,390
| +5% | +$261K | ﹤0.01% | 1280 |
|
|
2024
Q3 | $2.7M | Buy |
63,578
+16,406
| +35% | +$696K | ﹤0.01% | 1501 |
|
|
2024
Q2 | $1.23M | Buy |
47,172
+3,889
| +9% | +$102K | ﹤0.01% | 1802 |
|
|
2024
Q1 | $396K | Sell |
43,283
-16
| -0% | -$146 | ﹤0.01% | 2301 |
|
|
2023
Q4 | $120K | Hold |
43,299
| – | – | ﹤0.01% | 2687 |
|
|
2023
Q3 | $158K | Sell |
43,299
-453
| -1% | -$1.65K | ﹤0.01% | 2561 |
|
|
2023
Q2 | $261K | Sell |
43,752
-4,755
| -10% | -$28.4K | ﹤0.01% | 2424 |
|
|
2023
Q1 | $585K | Sell |
48,507
-1,462
| -3% | -$17.6K | ﹤0.01% | 2034 |
|
|
2022
Q4 | $435K | Sell |
49,969
-2,404
| -5% | -$20.9K | ﹤0.01% | 2195 |
|
|
2022
Q3 | $1.52M | Buy |
52,373
+1,058
| +2% | +$30.7K | ﹤0.01% | 1554 |
|
|
2022
Q2 | $2.13M | Sell |
51,315
-3,785
| -7% | -$157K | ﹤0.01% | 1590 |
|
|
2022
Q1 | $5.58M | Sell |
55,100
-33,765
| -38% | -$3.42M | ﹤0.01% | 1445 |
|
|
2021
Q4 | $13.1M | Buy |
88,865
+2,428
| +3% | +$357K | ﹤0.01% | 1366 |
|
|
2021
Q3 | $21.7M | Buy |
+86,437
| New | +$21.7M | ﹤0.01% | 1273 |
|